Sw480
The SW480 is a cell line derived from a human colorectal adenocarcinoma. It is commonly used in research to study the biology and pathogenesis of colorectal cancer.
Lab products found in correlation
18 protocols using sw480
Establishing Oxaliplatin-Resistant Colorectal Cancer Cell Lines
Colorectal Cancer Tissue Profiling
Cell cultures and irradiation. All the cell lines (fHC, CCL244, HCT116, SW480 and LOvO) were purchased from Shanghai Institute of Cell Biology (Shanghai, China) and maintained in DMEM supplemented with 10% fBS and antibiotics (100 U/ml penicillin G, 100 U/ml streptomycin sulfates; Gibco, Grand Island, NY, USA) at 37˚C in a humidified atmosphere containing 5% CO 2 . Cells were exposed to a single dose of X-ray irradiation from the linear accelerator (RadSource, Suwanee, GA, USA) at a dose rate of 1.15 Gy/min.
SiRNA construction and transfection. The siRNA sequences targeting human HOTAIR (si-HOTAIR) or negative control (NC) sequence were designed and synthesized by Genepharma (Shanghai, China) as shown in Table II. Cells were transfected with siRNA by Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA).
Colon Cancer Cell Line Transfection Protocol
Culturing and Authenticating Human CRC Cell Lines
Colon Cancer Tissue Collection and Cell Culture
Cell culture FIHC, HCT-116, HT-29, and SW480 cell lines were purchased from the Shanghai Institute of Cell Biology (Shanghai, China). The cell lines were cultured in Dulbecco's Modified Eagle's Medium (DMEM)/Nutrient Mixture F-12 Ham containing 10% fetal bovine serum, and maintained in a humidified incubator at 37°C with 5% CO 2 . The cells in logarithmic growth with 95% viability were subjected to further experiment.
Culturing Colon Cancer Cell Lines
Culturing Human Colon Cancer Cell Lines
Comparative Analysis of Colon Cancer Cell Lines
Overexpression of miR-1 in Colorectal Cancer
The cells were seeded into 6-well plates and transiently transfected with Lipofectamine 2000 (Invitrogen, San Diego, CA, USA) and miR-1 mimics or the miRNA mimic Negative Control (GenePharma, Shanghai, China), according to the manufacturer's instructions. Real-time PCR was performed to confirm the efficiency of transfection.
Modulating CRC Progression via CPEB3
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!